BioSpace News Archive

UCB announced data being presented at the American Epilepsy Society Annual Meeting, taking place December 1–5 in Orlando, Florida, that focus on the real-world experiences of people living with rare epilepsy syndromes and their caregivers, in addition to several other presentations of clinical data evaluating the efficacy, safety and tolerability of FINTEPLA as a treatment for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome.

Xenon Pharmaceuticals Inc., a neurology-focused biopharmaceutical company, announced it will provide updates on its neurology programs at the Annual Meeting of the American Epilepsy Society.

Merus N.V. announced updated interim clinical data on MCLA-129 from ongoing expansion cohorts in non-small cell lung cancer and in previously treated head and neck squamous cell carcinoma were presented at the European Society for Medical Oncology Asia Congress 2023.